BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BKYI • US09060C5076

0.61 USD
-0.04 (-6.15%)
At close: Feb 11, 2026
0.62 USD
+0.01 (+1.64%)
Pre-Market: 2/12/2026, 7:22:31 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BKYI. BKYI was compared to 277 industry peers in the Software industry. BKYI may be in some trouble as it scores bad on both profitability and health. BKYI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • BKYI had negative earnings in the past year.
  • BKYI had a negative operating cash flow in the past year.
  • In the past 5 years BKYI always reported negative net income.
  • In the past 5 years BKYI always reported negative operating cash flow.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -42.06%, BKYI is doing worse than 83.39% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -70.36%, BKYI is doing worse than 73.65% of the companies in the same industry.
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROIC N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • BKYI has a better Gross Margin (78.40%) than 75.81% of its industry peers.
  • BKYI's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BKYI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BKYI has more shares outstanding
  • The debt/assets ratio for BKYI is higher compared to a year ago.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -17.87, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BKYI (-17.87) is worse than 92.42% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that BKYI is not too dependend on debt financing.
  • BKYI has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -17.87
ROIC/WACCN/A
WACC12.17%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that BKYI should not have too much problems paying its short term obligations.
  • BKYI's Current ratio of 1.26 is on the low side compared to the rest of the industry. BKYI is outperformed by 62.82% of its industry peers.
  • BKYI has a Quick Ratio of 1.13. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.13, BKYI is not doing good in the industry: 68.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.13
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.55% over the past year.
  • The Revenue has decreased by -1.19% in the past year.
  • BKYI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.01% yearly.
EPS 1Y (TTM)90.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-27.78%

3.2 Future

  • BKYI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.20% yearly.
  • BKYI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.75% yearly.
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • BKYI's earnings are expected to grow with 35.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.2%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (2/11/2026, 8:08:24 PM)

Premarket: 0.62 +0.01 (+1.64%)

0.61

-0.04 (-6.15%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14
Earnings (Next)03-25
Inst Owners0.81%
Inst Owner Change9.27%
Ins Owners2.39%
Ins Owner Change5.19%
Market Cap6.61M
Revenue(TTM)6.32M
Net Income(TTM)-4.25M
Analysts82.86
Price Target2.04 (234.43%)
Short Float %1.23%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.63%
Min EPS beat(2)-30.72%
Max EPS beat(2)-22.55%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.88%
Min Revenue beat(2)-15.63%
Max Revenue beat(2)-2.13%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.05
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.58
BVpS0.56
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.4%
FCFM N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.7%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.13
Altman-Z -17.87
F-Score4
WACC12.17%
ROIC/WACCN/A
Cap/Depr(3y)8.01%
Cap/Depr(5y)11.47%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-27.78%
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.44%
OCF growth 3YN/A
OCF growth 5YN/A

BIO-KEY INTERNATIONAL INC / BKYI FAQ

What is the fundamental rating for BKYI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BKYI.


What is the valuation status for BKYI stock?

ChartMill assigns a valuation rating of 1 / 10 to BIO-KEY INTERNATIONAL INC (BKYI). This can be considered as Overvalued.


How profitable is BIO-KEY INTERNATIONAL INC (BKYI) stock?

BIO-KEY INTERNATIONAL INC (BKYI) has a profitability rating of 1 / 10.


What is the earnings growth outlook for BIO-KEY INTERNATIONAL INC?

The Earnings per Share (EPS) of BIO-KEY INTERNATIONAL INC (BKYI) is expected to grow by 73.12% in the next year.


How sustainable is the dividend of BIO-KEY INTERNATIONAL INC (BKYI) stock?

The dividend rating of BIO-KEY INTERNATIONAL INC (BKYI) is 0 / 10 and the dividend payout ratio is 0%.